325 related articles for article (PubMed ID: 25365234)
1. Targeting mitochondrial function for the treatment of breast cancer.
Deus CM; Coelho AR; Serafim TL; Oliveira PJ
Future Med Chem; 2014 Sep; 6(13):1499-513. PubMed ID: 25365234
[TBL] [Abstract][Full Text] [Related]
2. Novel targeted agents for the treatment of advanced breast cancer.
de la Vega M; Díaz-Cantón E; Alvarez RH
Future Med Chem; 2012 May; 4(7):893-914. PubMed ID: 22571614
[TBL] [Abstract][Full Text] [Related]
3. New derivatives of lupane triterpenoids disturb breast cancer mitochondria and induce cell death.
Serafim TL; Carvalho FS; Bernardo TC; Pereira GC; Perkins E; Holy J; Krasutsky DA; Kolomitsyna ON; Krasutsky PA; Oliveira PJ
Bioorg Med Chem; 2014 Nov; 22(21):6270-87. PubMed ID: 25245673
[TBL] [Abstract][Full Text] [Related]
4. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
5. Targeted drug delivery for breast cancer treatment.
Jin S; Ye K
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):143-53. PubMed ID: 23394116
[TBL] [Abstract][Full Text] [Related]
6. Promising strategy developed to target drug-resistant cancer cells.
Thorne J
Future Med Chem; 2014 Apr; 6(6):603. PubMed ID: 25028759
[No Abstract] [Full Text] [Related]
7. Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids.
Mandujano-Tinoco EA; Gallardo-Pérez JC; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
Biochim Biophys Acta; 2013 Mar; 1833(3):541-51. PubMed ID: 23195224
[TBL] [Abstract][Full Text] [Related]
8. The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway.
Akiyoshi T; Matzno S; Sakai M; Okamura N; Matsuyama K
Cancer Chemother Pharmacol; 2009 Dec; 65(1):143-50. PubMed ID: 19449007
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria: An intriguing target for killing tumour-initiating cells.
Yan B; Dong L; Neuzil J
Mitochondrion; 2016 Jan; 26():86-93. PubMed ID: 26702582
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and induction of apoptosis of human breast cancer cells by novel platinum(II) complexes.
Bielawski K; Czarnomysy R; Muszyńska A; Bielawska A; Popławska B
Environ Toxicol Pharmacol; 2013 Mar; 35(2):254-64. PubMed ID: 23376176
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria as therapeutic targets for the treatment of malignant disease.
Fulda S; Kroemer G
Antioxid Redox Signal; 2011 Dec; 15(12):2937-49. PubMed ID: 21644835
[TBL] [Abstract][Full Text] [Related]
12. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
Zhang E; Zhang C; Su Y; Cheng T; Shi C
Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
[TBL] [Abstract][Full Text] [Related]
13. Restoration of mitochondria function as a target for cancer therapy.
Bhat TA; Kumar S; Chaudhary AK; Yadav N; Chandra D
Drug Discov Today; 2015 May; 20(5):635-43. PubMed ID: 25766095
[TBL] [Abstract][Full Text] [Related]
14. Synthetic phosphoethanolamine induces cell cycle arrest and apoptosis in human breast cancer MCF-7 cells through the mitochondrial pathway.
Ferreira AK; Meneguelo R; Pereira A; Filho OM; Chierice GO; Maria DA
Biomed Pharmacother; 2013 Jul; 67(6):481-7. PubMed ID: 23773853
[TBL] [Abstract][Full Text] [Related]
15. Bufalin loaded biotinylated chitosan nanoparticles: an efficient drug delivery system for targeted chemotherapy against breast carcinoma.
Tian X; Yin H; Zhang S; Luo Y; Xu K; Ma P; Sui C; Meng F; Liu Y; Jiang Y; Fang J
Eur J Pharm Biopharm; 2014 Aug; 87(3):445-53. PubMed ID: 24846793
[TBL] [Abstract][Full Text] [Related]
16. Approaches for targeting mitochondria in cancer therapy.
D'Souza GG; Wagle MA; Saxena V; Shah A
Biochim Biophys Acta; 2011 Jun; 1807(6):689-96. PubMed ID: 20732297
[TBL] [Abstract][Full Text] [Related]
17. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells.
Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T
Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial-dependent anticancer activity of δ-tocotrienol and its synthetic derivatives in HER-2/neu overexpressing breast adenocarcinoma cells.
Viola V; Ciffolilli S; Legnaioli S; Piroddi M; Betti M; Mazzini F; Pierpaoli E; Provinciali M; Galli F
Biofactors; 2013; 39(4):485-93. PubMed ID: 23361894
[TBL] [Abstract][Full Text] [Related]
19. Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells.
Kallio A; Zheng A; Dahllund J; Heiskanen KM; Härkönen P
Apoptosis; 2005 Dec; 10(6):1395-410. PubMed ID: 16215679
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effect of (E)-2-hydroxy-3',4,5'-trimethoxystilbene on breast cancer cells by mitochondrial depolarization.
Chae YS; Kim JG; Jung HJ; Yang JD; Jung JH; Aiyar SE; Kim S; Park H
Cancer Chemother Pharmacol; 2011 Aug; 68(2):349-58. PubMed ID: 20978764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
